Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

Presentation TCT 2025

Session evaluation and key learnings

Presenter: Raj Makkar

October 28, 2025

Presentation TCT 2025

What’s next for structural heart programs: TAVR and beyond

Presenter: Raj Makkar

October 28, 2025

Presentation TCT 2025

Interventionalist's Viewpoint

Presenter: Raj Makkar

October 28, 2025

Presentation TCT 2025

Siegel THV: EFS Results

Presenter: Raj Makkar

October 27, 2025

Presentation TCT 2025

M-TEER in Primary MR: What the Clinical Evidence Shows

Presenter: Raj Makkar

October 27, 2025

Presentation TCT 2025

Evaluating Real-World Outcomes of the EVOQUE Valve in Early Commercial Experience from the STS/ACC TVT Registry

Presenter: Raj Makkar

October 26, 2025

Presentation NY Valves 2025

Contemporary Transcatheter Options for AR: Where Do We Stand?

Presenter: Raj Makkar

June 26, 2025

Presentation NY Valves 2025

The JenaValve TAVR System: Lessons Learned from the Continued Access Study

Presenter: Raj Makkar

June 26, 2025

Presentation NY Valves 2025

SIEGEL TAVR: Technology Update and EFS Results (Mirus Medical)

Presenter: Raj Makkar

June 26, 2025

Presentation NY Valves 2025

Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II)

Presenter: Raj Makkar

June 25, 2025

News Daily News

‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use

Yael L. Maxwell

June 18, 2025

News Daily News EuroPCR 2025

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

Michael O'Riordan

May 28, 2025

News Conference News ACC 2025

More ALIGN-AR Data Bolster Potential for a Dedicated AR Device

Yael L. Maxwell

March 30, 2025

News Conference News ACC 2025

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

Michael O'Riordan

March 30, 2025

News Industry News

Pi-Cardia Reports First Commercial Cases with ShortCut™

March 03, 2025

Video

» Interview

Beyond the Data: The ALIGN-AR Trial

April 18, 2025

Advertisement

Session evaluation and key learnings

What’s next for structural heart programs: TAVR and beyond

Interventionalist's Viewpoint

Siegel THV: EFS Results

M-TEER in Primary MR: What the Clinical Evidence Shows

Evaluating Real-World Outcomes of the EVOQUE Valve in Early Commercial Experience from the STS/ACC TVT Registry

Contemporary Transcatheter Options for AR: Where Do We Stand?

The JenaValve TAVR System: Lessons Learned from the Continued Access Study

SIEGEL TAVR: Technology Update and EFS Results (Mirus Medical)

Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II)

‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

More ALIGN-AR Data Bolster Potential for a Dedicated AR Device

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

Pi-Cardia Reports First Commercial Cases with ShortCut™

Beyond the Data: The ALIGN-AR Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content